- ￥571 - 5717
- MedChemExpress(MCE)
- 美国
- HY-136579
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
ERK-IN-3
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
2055597-12-9
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1564.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥571.0 |
| 规格： | 5 mg | 产品价格： | ￥1500.0 |
| 规格： | 10 mg | 产品价格： | ￥2475.0 |
| 规格： | 25 mg | 产品价格： | ￥4084.0 |
| 规格： | 50 mg | 产品价格： | ￥5717.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
ASN007
CAS No. : 2055597-12-9
MCE 国际站：ASN007
产品活性：ASN007 (ERK-IN-3) 是一种有效和具有口服活性的 ERK 抑制剂。 ASN007 以较低的 IC50 值抑制 ERK1/2。 ASN007 可用于研究由 RAS 突变驱动的癌症。
研究领域：MAPK/ERK Pathway | Stem Cell/Wnt
作用靶点：ERK
In Vitro: ASN007 (ERK-IN-3) inhibits the phosphorylation of ERK1/2 substrates such as RSK1, FRA1, and Elk1 in various cell lines.
ASN007 showes single-digit nanomolar antiproliferative activity that is selective for MAPK-pathway dependent cancer cell lines.
In Vivo: ASN007 (ERK-IN-3) (daily p.o.) inhibits tumor growth in multiple BRAF and KRAS mutant xenograft models in mice and was well tolerated at efficacious doses.
相关产品：Covalent Screening Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Covalent Screening Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Orally Active Compound Library | Glutamine Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Pain-Related Compound Library | Serine/Threonine Kinase Inhibitor Library | PD98059 | Yoda 1 | SCH772984 | TBHQ | Tauroursodeoxycholate | Ulixertinib | Honokiol | Astragaloside IV | Piperlongumine | Ravoxertinib | Temuterkib | C16-PAF | Lidocaine | FR 180204 | BIX02189 | XMD8-92 | MK-8353 | 6-OAU | Patritumab | trans-Zeatin | SEW2871 | Urolithin B | VX-11e | Pamoic acid | Pachymic acid | AG126 | Lysophosphatidylcholines | LM22B-10
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1. A液（0.2M磷酸二氢钠水溶液）： NaH2 PO4 ・H2 O 27.6g，溶于蒸馏水中，稀释至1000ml。2. B液（0.2M磷酸氢二钠水溶液）：Na2 HPO4 ・7H2 O 53.6g (或Na2 HPO4 ・12 H2 O 71.6g或Na2 HPO4 ・2 H2 O 35.6g ) 加蒸馏水溶解，加水至1000ml。3. 不同pH值磷酸盐缓冲液（PB）缓冲液的配制A液X ml (参照下表) 中，加入B液Y ml，为0.2M PB。若再加蒸馏水至200ml则成0.1M PB
Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma. Aberrations of the p53 and Rb tumour suppressor genes were examined in 12 human hepatocellular carcinoma (HCC)-derived cell lines from different geographic areas and 9 local HCCs
子表 氨基酸 密码 频率 氨基酸 密码 频率 Leu TTA 15.6 His CAT 11.9 TTG 31.2 CAC 9.1 CTT 15.7 Gln CAA 25.3 CTC 7.5 CAG 16.2 CTA 10.9 Asn
技术资料暂无技术资料 索取技术资料
